SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001047469-15-007634
Filing Date
2015-10-01
Accepted
2015-10-01 06:01:16
Documents
20

Document Format Files

Seq Description Document Type Size
1 424B4 a2226174z424b4.htm 424B4 2183081
2 G559585.JPG g559585.jpg GRAPHIC 28099
3 G119537.JPG g119537.jpg GRAPHIC 67133
4 G121996.JPG g121996.jpg GRAPHIC 77009
5 G393531.JPG g393531.jpg GRAPHIC 39779
6 G407866.JPG g407866.jpg GRAPHIC 58527
7 G766180.JPG g766180.jpg GRAPHIC 100905
8 G877907.JPG g877907.jpg GRAPHIC 32557
9 G8770.JPG g8770.jpg GRAPHIC 62162
10 G36590.JPG g36590.jpg GRAPHIC 25533
11 G435121.JPG g435121.jpg GRAPHIC 98605
12 G784076.JPG g784076.jpg GRAPHIC 59443
13 G369388.JPG g369388.jpg GRAPHIC 197024
14 G196700.JPG g196700.jpg GRAPHIC 64647
15 G69549.JPG g69549.jpg GRAPHIC 65632
16 G201629.JPG g201629.jpg GRAPHIC 33834
17 G522893.JPG g522893.jpg GRAPHIC 30503
18 G516051.JPG g516051.jpg GRAPHIC 82481
19 G9237.JPG g9237.jpg GRAPHIC 57342
20 G361638.JPG g361638.jpg GRAPHIC 44429
  Complete submission text file 0001047469-15-007634.txt   3874801
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-206544 | Film No.: 151135230
SIC: 2834 Pharmaceutical Preparations